NASDAQ:BLPH - Bellerophon Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$0.64 +0.05 (+8.47 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$0.59
Today's Range$0.59 - $0.64
52-Week Range$0.47 - $3.30
Volume431,337 shs
Average Volume349,972 shs
Market Capitalization$44.10 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.02

Analyst Ratings

Bellerophon Therapeutics (NASDAQ:BLPH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Bellerophon Therapeutics in the last 12 months. Their average twelve-month price target is $3.00, suggesting that the stock has a possible upside of 368.75%. The high price target for BLPH is $3.00 and the low price target for BLPH is $3.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.00$3.00$3.00$3.00
Price Target Upside: 368.75% upside328.57% upside347.76% upside400.00% upside

Bellerophon Therapeutics (NASDAQ:BLPH) Consensus Price Target History

Price Target History for Bellerophon Therapeutics (NASDAQ:BLPH)

Bellerophon Therapeutics (NASDAQ:BLPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/8/2019Maxim GroupSet Price TargetBuy$3.00LowView Rating Details
1/29/2019HC WainwrightReiterated RatingBuy$3.00LowView Rating Details
(Data available from 5/24/2017 forward)
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel